Image

Non-invasive Early Oxygen- Reserve-index (ORI) Determination to Prevent Hypoxaemia During Endotracheal Intubation

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The purpose of this study is to determine whether ORI monitoring increases the lowest oxygen saturation level during the interval between the first laryngoscopy (defined as introduction of the laryngoscope into the mouth) and the end of the second minute after successful ETI.

Description

The trial population will be adults (18 years of age or older) who need endotracheal intubation while hospitalized in ICU

Eligibility

Inclusion Criteria:

  • ICU admission and need for ETI to allow mechanical ventilation
  • Need for supplemental oxygen (via any device and at any flow rate) to obtain SpO2>97%
  • Patient or next of kin informed about the study and having consented to participation of the patient in the study (patients with coma are unable to consent). If patient is no competent and no next of kin can be contacted during screening for the study, trial inclusion will be completed as an emergency procedure by the ICU physician, in compliance with French law
  • Patients affiliated to a social security system

Exclusion Criteria:

  • Patients participating in intubation research with an oxygenation endpoint will not be eligible for inclusion
  • Fiberoptic intubation required according to physician in charge
  • Contra-indications to laryngoscopy (e.g., unstable spinal lesion)
  • Insufficient time to include and randomise the patient (e.g., because of cardiac arrest)
  • Age <18 years
  • Currently pregnant or breastfeeding
  • Correctional facility inmate
  • Under guardianship, curatorship or under protection of justice

Study details

Intensive Care Unit

NCT05867875

Nantes University Hospital

14 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.